Sign in
Taking people in United StatesNo phase

A Study to Evaluate the SENSE Device's Ability to Detect TBI

Key facts

Who runs it
Sense Diagnostics, LLC
Where
Charleston, Cincinnati, Gainesville, Houston, Pittsburgh, and San Antonio, United StatesSee the 6 sites
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
11 Jul 2025
Planned end
30 Jun 2026
Type of study
Observational, 3 groups
Treatments tested
  • SENSE device
Record updated
25 November 2025

Who can take part

Age
22 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • • Male or female adults age 22 and older; Patients with TBI who have a head CT scan obtained in the mobile stroke unit, emergency department, or hospital, ordered by a treating clinician OR control subjects with normal brain health; For patients with traumatic intracranial hemorrhage, blood is visible on ≥ 3 consecutive axial CT slices; Signed written informed consent by study subject or, if subject is unable, by subject's next of kin or legally authorized representative; Willingness and ability to comply with schedule for study procedures

Who cannot take part

  • • Female patients who are pregnant or lactating; SENSE Device is unable to be placed within 6 hours of a standard of care head CT and within 24 hours of injury; Open skull fracture (closed skull fracture is not an exclusion); Metallic intracranial clip, coil, or device (such as metallic ICP monitor); Presence or history of any other condition or finding that, in the investigator's opinion, makes the patient unsuitable as a candidate for the SENSE Device monitoring or study participation or may confound the outcome of the study; Planned placement of an intraventricular catheter prior to study enrollment; Planned intracranial surgery prior to study enrollment; Current participation in a medical or surgical interventional clinical trial; Use of continuous EEG monitoring at the time of enrollment; Clinical uncertainty about the presence or absence of hemorrhage on the enrolling head CT; Control subjects with normal brain health will have no known history of seizure, stroke, brain tumor, TBI requiring emergency room evaluation, concussion within the previous 6 months, hydrocephalus, intracranial vascular malformation, other structural brain disease, or intracranial surgery. Benign headache disorders (e.g. migraine headache, tension headache), and mild concussion > 6 months prior to enrollment are not exclusions

Where in United States

  • MUSCCharleston, United StatesContact: Paige HallTaking people
  • University of CincinnatiCincinnati, United StatesContact: Jason McMullan, MDTaking people
  • University of FloridaGainesville, United StatesContact: Hector Meza Comparan, MDTaking people
  • UT HoustonHouston, United StatesContact: Arun KaneTaking people
  • University of PittsburghPittsburgh, United StatesContact: Evan GuTaking people
  • UTSASan Antonio, United StatesContact: Martha De La MoraTaking people

About the trial

What the trial wants to find out

The study population will consist of 3 mutually-exclusive sets of patients and subjects:

Read full original descriptionShow less

* TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health.

Research subjects ages 22 and older will be enrolled. All TBI patients must be monitored with the SENSE Device within 6 hours of a diagnostic head CT scan ordered by a treating clinician and within 24 hours of injury.

The 3 groups in the trial

  • TBI patients with intracranial bleeding

    50 patients with TBI with intracranial bleeding

    Treatment: SENSE device

  • TBI patients without intracranial bleeding

    50 patients with TBI without intracranial bleeding

    Treatment: SENSE device

  • Control subjects with normal brain health

    50 control subjects with normal brain health

    Treatment: SENSE device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Non-randomized, Sequentially-enrolled, Multi-center, Phase II Study to Evaluate the SENSE Device's Ability to Detect Traumatic Brain Injury
Record updated
25 November 2025